Senti Biosciences: Funding, Investors & Team (Sep 2026)
Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell and gene therapies in order to enhance their therapeutic effectiveness against a broad range of diseases that conventional medicines do not readily address. For more information, please visit the Senti Bio website at https://www.sentibio.com.
Senti Biosciences has raised $157M across 5 funding rounds on record, the most recent an undisclosed round of $1.0M announced in May 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Senti Biosciences Company Profile and Key Stats
Latest funding round on record: May 2025.
Senti Biosciences Funding Rounds
Senti Biosciences raised $105M in a Series B announced in Jan 2021.
1.3 years later, a Convertible Note of $5.2M was announced in May 2022.
2.2 years later, an undisclosed round of $8.0M was announced in Jul 2024.
5 months later, an undisclosed round of $37.6M was announced in Dec 2024.
5 months later, an undisclosed round of $1.0M was announced in May 2025.
Senti Biosciences Founders and Leadership Team
Contact details for the Senti Biosciences team: 1 of 3 have an email address on file.
Start 14-day free trial →Senti Biosciences Funding Compared to Other Biotechnology Startups
Senti Biosciences' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Senti Biosciences in Biotechnology and South San Francisco
Companies Similar to Senti Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Senti Biosciences Funding FAQs
What does Senti Biosciences do?
Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell and gene therapies in order to enhance their therapeutic effectiveness against a broad range of diseases that conventional medicines do not readily address. For more information, please visit the Senti Bio website at https://www.sentibio.com.
How much funding has Senti Biosciences raised?
Senti Biosciences has raised $157M across 5 rounds on record. The most recent is an undisclosed round of $1.0M announced in May 2025.
When did Senti Biosciences last raise funding?
Senti Biosciences' most recent funding round on record is an undisclosed round of $1.0M, announced in May 2025.
Who founded Senti Biosciences?
FundedIQ lists Philip Lee (Founder), Timothy K Lu (Founder) at Senti Biosciences.
Who is the CEO of Senti Biosciences?
Tim Lu is listed as CEO at Senti Biosciences.
Where is Senti Biosciences headquartered?
Senti Biosciences is based in South San Francisco, California, United States.
How many employees does Senti Biosciences have?
Senti Biosciences is in the 101-250 employee band.
How does Senti Biosciences' funding compare to other Biotechnology startups?
Senti Biosciences' latest round of $1.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Senti Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Senti Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.